Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer
Toni M. Brand(University of Wisconsin–Madison), Jennifer R. Grandis(University of California, San Francisco), Stefan Hartmann(Universitätsklinikum Würzburg), Michelle A. Ozbun(University of New Mexico), Margaret Soucheray(Gladstone Institutes), Nevan J. Krogan(QB3), Sourav Bandyopadhyay(University of California, San Francisco), Umamaheswar Duvvuri(City University of New York), Daniel E. Johnson(UCSF Helen Diller Family Comprehensive Cancer Center), Carolyn Kemp(University of Pittsburgh Medical Center), Theresa LaVallee(Achillion Pharmaceuticals (United States)), Julie E. Bauman(George Washington University), Max V. Ranall(The University of Queensland), Rachel A. O’Keefe(University of California, San Francisco), Yan Zeng(The University of Texas MD Anderson Cancer Center), Hua Li(Affiliated Hospital of Southwest Medical University), Neil E. Bhola(University of California, San Francisco)
Cited by 5
Related Papers
Head and neck squamous cell carcinoma
|Nature Reviews Disease Primers|2020|4k
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
|Cell|2020|1.2k
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization
|Proceedings of the National Academy of Sciences|2004|1.1k